PDS Biotechnology Corporation
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-6.4M | $-6.4M | — | $1.1M |
| Jun 2022 | $-5.9M | $-5.9M | — | $1.3M |
| Sep 2022 | $-5.9M | $-5.9M | — | $1.3M |
| Dec 2022 | $-7.5M | $-7.5M | — | $1.4M |
| Mar 2023 | $-13.2M | $-13.2M | — | $2.1M |
| Jun 2023 | $-4.8M | $-4.8M | — | $2.1M |
| Sep 2023 | $-7.2M | $-7.2M | — | $2.1M |
| Dec 2023 | $-8.5M | $-8.5M | — | $1.4M |
| Mar 2024 | $-9.9M | $-9.9M | — | $1.6M |
| Jun 2024 | $-8.9M | $-8.9M | — | $1.8M |
| Sep 2024 | $-8.0M | $-8.0M | — | $1.8M |
| Dec 2024 | $-8.2M | $-8.2M | — | $1.6M |
| Mar 2025 | $-9.0M | $-9.0M | — | $1.3M |
| Jun 2025 | $-9.1M | $-9.1M | — | $448.0K |
| Sep 2025 | $-5.9M | $-5.9M | — | $1.2M |
| Dec 2025 | $-3.7M | $-3.7M | — | $1.2M |
| Mar 2026 | $-4.4M | $-4.4M | — | $1.2M |
| Jun 2026 | $-2.8M | $-2.8M | — | $1.1M |